As tirzepatide and other GLP-1based therapies continue to dominate headlines, this study offers an important glimpse at where the future of inflammatory disease treatment may be headed
Johnson, B., Milstead, M., Thomas, O., McGlasson, T., Green, L., Kreider, R., & Jones, R
Our clinical flow often looks like this: Baseline optimization: hydration, protein intake, sleep, circadian exposure to light, movement, and stress reduction
Weekly self-administered subcutaneous injection using a small needle (similar to insulin)
The regression-like pattern is seldom documented with dermoscopic monitoring, but is peculiar enough to allow a clinicopathological differential diagnosis between melanoma with regression and its main benign simulator, the so-called sclerosing nevus with pseudomelanomatous features or compound nevus with regression-like fibrosis (58, 59)